148 related articles for article (PubMed ID: 18572032)
1. The editor's roundtable: bare-metal stents versus drug-eluting stents-indications and complications.
Friedewald VE; Kastrati A; Roberts WC; Vetrovec GW; Windecker S
Am J Cardiol; 2008 Jul; 102(1):32-9. PubMed ID: 18572032
[No Abstract] [Full Text] [Related]
2. Bare-metal versus drug-eluting coronary stents.
Agostoni P; Vermeersch P
N Engl J Med; 2008 Jun; 358(23):2516-7; author reply 2517-8. PubMed ID: 18536096
[No Abstract] [Full Text] [Related]
3. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.
Roukoz H; Bavry AA; Sarkees ML; Mood GR; Kumbhani DJ; Rabbat MG; Bhatt DL
Am J Med; 2009 Jun; 122(6):581.e1-10. PubMed ID: 19486720
[TBL] [Abstract][Full Text] [Related]
6. [Drug-eluting stents--for all, for some or for none?--Editorial].
Kocka V; Widimský P
Vnitr Lek; 2007 Oct; 53(10):1033-4. PubMed ID: 18072425
[No Abstract] [Full Text] [Related]
7. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
Kumbhani DJ; Bavry AA; Bhatt DL
Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
[TBL] [Abstract][Full Text] [Related]
8. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study.
Burzotta F; Parma A; Pristipino C; Manzoli A; Belloni F; Sardella G; Rigattieri S; Danesi A; Mazzarotto P; Summaria F; Romagnoli E; Prati F; Trani C; Crea F
Eur Heart J; 2008 Dec; 29(24):3011-21. PubMed ID: 18987096
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting versus bare-metal stents: when and for whom?
Beyar R; Nikolsky E
J Invasive Cardiol; 2008 Mar; 20(3):105-6. PubMed ID: 18316824
[No Abstract] [Full Text] [Related]
10. The balance of risks and benefits of drug-eluting versus bare-metal stents.
Pfisterer M; Brunner-La Rocca HP; Kaiser C
J Am Coll Cardiol; 2008 Mar; 51(9):972; author reply 972-3. PubMed ID: 18308171
[No Abstract] [Full Text] [Related]
11. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
13. Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus.
Maeng M; Jensen LO; Kaltoft A; Hansen HH; Bøttcher M; Lassen JF; Thayssen P; Krusell LR; Rasmussen K; Pedersen L; Sørensen HT; Johnsen SP; Thuesen L
Am J Cardiol; 2008 Jul; 102(2):165-72. PubMed ID: 18602515
[TBL] [Abstract][Full Text] [Related]
14. Heightened awareness of the thrombosis potential of drug-eluting stents may save lives.
From RP; Tretsven J; O'Sullivan C
J Clin Anesth; 2008 Dec; 20(8):624-5; author reply 626. PubMed ID: 19100939
[No Abstract] [Full Text] [Related]
15. Debating the risks of drug-eluting stents.
Shuchman M
N Engl J Med; 2007 Jan; 356(4):325-8. PubMed ID: 17251527
[No Abstract] [Full Text] [Related]
16. Perioperative management of patients with coronary stents.
Brilakis ES; Banerjee S; Berger PB
J Am Coll Cardiol; 2007 Jun; 49(22):2145-50. PubMed ID: 17543633
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery stents: II. Perioperative considerations and management.
Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents is their future as bright as their past?
Kastrati A; Schömig A
J Am Coll Cardiol; 2007 Jul; 50(2):146-8. PubMed ID: 17616298
[No Abstract] [Full Text] [Related]
20. Is implantation of drug-eluting stents a Faustian choice?
Brener SJ
J Invasive Cardiol; 2010 Oct; 22(10):465-6. PubMed ID: 20944184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
